期刊文献+

秋水仙碱对肾间质纤维化防治作用的形态学观察 被引量:4

A morphological study for the effects of colchicine on renal interstitial fibrosis in rats with unilatera ureteral obstruction
暂未订购
导出
摘要 目的 观察秋水仙碱对肾间质纤维化的保护作用。方法  2 6只SD大鼠随机被分成 3组 :假手术组 (n =6 ) ;对照组 (n =10 ) ;治疗组 (n =10 ) ,单侧输尿管结扎 (UUO)基础上予秋水仙碱10 0 μg/(kg·d)腹腔注射 ,每周 5天。 3周后处死所有大鼠并进行形态学研究。 结果 治疗组肾小管间质浸润的炎症细胞数为 (1738 4 4± 910 87)个 /mm2 ,明显少于对照组 (6 32 2 0 5± 1198 18)个 /mm2 ,(P <0 0 0 1) ;肾间质纤维化指数前者也明显低于后者 (分别为 2 2 6 7± 17 6 1及 72 92± 9 86 ,P <0 0 0 1) ;肾小管损伤程度对照组和治疗组分别为 (2 4 7± 0 4 7)分和 (1 4 3± 0 6 5 )分 ,后者明显轻于前者 (P <0 0 5 )。结论 秋水仙碱对肾间质纤维化有较好的防治作用。 Objective To observe the effects of colchicine on renal interstitial fibrosis in rats with unilateral ureteral obstruction (UUO).Methods 26 Sprague Dawley rats were divided into three groups:the colchicine treated group (10 rats):UUO+colchicine 100μg/(kg·d) by intraperitoneally(I.P) for 5 days per week,the saline treated group (10 rats):UUO+saline 100μg/(kg·d) by I.P for 5 days per week,and control group (6 rats).All rats were put to death at three weeks and the renal samples were used in morphological research.Results The numbers of inflammatory cells infiltration in colchicine treated group rats significantly decreased compared to that in saline treated group (1*#738 44 ±910 87 cells/mm 2 vs. 6*#322 05 ± 1*#198 18 cells/mm 2, P< 0 001).The index of interstitial fibrosis in colchicine treated rats also significantly reduced compared to that in saline treated rats (22 67±17 61 vs.72 92±9 86, P< 0 001).Meanwhile,the tubular lesions in saline treated rats were severer than that in colchicine treated rats (2 47±0 47 vs.1 43±0 65 P< 0 05).Conclusion Colchicine had beneficial effects on interstitial fibrosis in rats with UUO Sprague Dawley.
出处 《江苏医药》 CAS CSCD 北大核心 2002年第8期583-585,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅重点资助项目 (编号 :H990 6) 江苏省教委资助项目 (编号 :99KDJ3 2 0 0 11)
关键词 肾脏纤维化 秋水仙碱 防治 Kidney Fibrosis Colchicine
  • 相关文献

参考文献10

  • 1[1]Ben-Chetrit E,Levy M.Colchicine:1998 update.Semin Arthritis Rheum,1998,28:48-59.
  • 2[2]Sullivan TP,King LE,Boyd AS.Colchicine in dermatology.J Am Acad Dermatol,1998,39:993-999.
  • 3[3]Lange U,Schumann C,Schmidt KL.Current aspects of colchicine therapy:classical indications and new therapeutic uses.Eur J Med Res,2001,6:150-160.
  • 4[4]Sobh M,Sabry A,Moustafa F,et al.Effect of colchicine on chronic ciclosporin nephrotoxicity in sprague-dawley rats.Nephron,1998,79:452-457.
  • 5[5]Matsumoto T,Mizunoe Y.Suitability of colchicines and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili.Nephron,1990,56:130-135.
  • 6[6]McClurkin CJ,Phan SH,Hsu CH.Moderate protection of renal function and reduction of fibrosis by colchicines in a model of anti-GBM disease in the rabbit.J Am Soc Nephrol,1990,1:257-265.
  • 7[7]Zeisberg M,Strutz F,Muller GA.Renal fibrosis:an update.Curr Opin Nephrol Hypertens,2001,10:315-320.
  • 8[8]Eddy AA.Molecular basis of renal fibrosis.Pediatr Nephrol,2000,15:290-301.
  • 9[9]Dong C,Li Z,Alvarez RJ,et al.Microtubule binding to smads may regulate TGF beta activity.Mol Cell,2000,5:27-34.
  • 10[10]Haruyama T,Ajioka I,Akaike T,et al.Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling.Biochem Biophys Res Commun,2000,272:681-686.

同被引文献57

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部